Ultra-hypofractionated radiotherapy delivered over 2 weeks is noninferior to conventionally fractionated radiotherapy for patients with prostate cancer.

Experts say this kind of research can really change how prostate cancer is treated around the world. Professor Matthias ...

Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course ...

To evaluate the financial burdens and travel times experienced by patients with cancer receiving radiotherapy (RT) in Saudi Arabia and to explore the potential role of hypofractionated RT (HFRT) and ...

"Long-term outcomes and treatment efficacy in high-risk prostate cancer patients treated with stereotactic extreme hypofractionated radiotherapy," reports on 262 men over the age of 70 or with ...

The CyberKnife System facilitates ultra-hypofractionated radiation therapy – very high doses of precisely targeted radiation ...

The 2 groups--those receiving ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy--had similar overall survival, which was 81% and 79%, respectively, at 10 years.

Abstract n° E25-5025: “Hypofractionated breast radiotherapy for 1 week vs 3 weeks: 10-year efficacy and late normal tissue effects in the FAST-Forward randomised trial”, presented on 3 May at ...

The CyberKnife System facilitates ultra-hypofractionated radiation therapy – very high doses of precisely targeted radiation are delivered in a few days versus conventional fractionation where ...